Literature DB >> 16600300

Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics.

V Medina-Hernández1, J Ramos-Loyo, S Luquin, L F Cerdán Sánchez, J García-Estrada, A Navarro-Ruiz.   

Abstract

It is well-known that increased lipid peroxidation and failure of antioxidant mechanisms leads to neuronal damage in schizophrenic patients. However, this neurodegenerative mechanism has not been studied in treatment refractory schizophrenics (TRS). Therefore, the main purpose of this study was to determine neuronal damage in TRS in comparison to non-refractory schizophrenics (NRS) by means of quantitative analysis of lipid peroxidation and neuron specific enolase (NSE) related to the psychopathology severity. Two groups of paranoid schizophrenics, TRS and NRS, and a group of healthy controls (CO) were assembled (n=13). Lipid peroxidation was analyzed through spectrophotometry for quantification of malonaldehyde (MDA) and 4-hydroxynonenal (4-HNE) serum concentrations. As well, serum NSE was quantified by radioimmunoassay (ELSA). Psychopathology was evaluated using the brief psychiatric rating scale (BPRS) and the positive and negative symptoms scale (PANSS). TRS showed significant higher concentrations of lipoperoxides by-products and NSE, than NRS and CO. Clinical scores also revealed a more severe pathology in TRS, than in NRS. Raised lipoperoxidation correlated with higher delusions and emotional withdrawal symptoms, and increased NSE correlated with a lower flow of the conversation and lack of spontaneity. All these results together suggest that TRS patients suffer a greater lipid peroxidation and neuronal damage than NRS, apparently related to worsening of some of the psychiatric symptoms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600300     DOI: 10.1016/j.jpsychires.2006.02.010

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  14 in total

1.  Altered Expression of Glucocorticoid Receptor and Neuron-Specific Enolase mRNA in Peripheral Blood in First-Episode Schizophrenia and Chronic Schizophrenia.

Authors:  Yong Liu; Yamei Tang; Cunyan Li; Huai Tao; Xiudeng Yang; Xianghui Zhang; Xuyi Wang
Journal:  Front Psychiatry       Date:  2020-08-12       Impact factor: 4.157

2.  Meta-analysis of oxidative stress in schizophrenia.

Authors:  Joshua Flatow; Peter Buckley; Brian J Miller
Journal:  Biol Psychiatry       Date:  2013-05-15       Impact factor: 13.382

3.  Glial and neuronal damage markers in patients with anorexia nervosa.

Authors:  Stefan Ehrlich; Roland Burghardt; Deike Weiss; Harriet Salbach-Andrae; Eugenia Maria Craciun; Klaus Goldhahn; Burghard F Klapp; Ulrike Lehmkuhl
Journal:  J Neural Transm (Vienna)       Date:  2008-03-04       Impact factor: 3.575

4.  Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia.

Authors:  Ahmad Ghanizadeh; Michael Berk
Journal:  Med Gas Res       Date:  2013-06-06

5.  Oxidative stress in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

6.  GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients.

Authors:  Denise S Pinheiro; Rodrigo da S Santos; Rodrigo B de Brito; Aline Helena da S Cruz; Paulo C Ghedini; Angela A S Reis
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

7.  Determining Pro-Oxidant Antioxidant Balance (PAB) and Total Antioxidant Capacity (TAC) in Patients with Schizophrenia.

Authors:  Farnaz Zahedi Avval; Niloufar Mahmoudi; Abolfazl Nosrati Tirkani; Lida Jarahi; Daryoush Hamidi Alamdari; Seyed Alireza Sadjadi
Journal:  Iran J Psychiatry       Date:  2018-07

Review 8.  The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.

Authors:  Steven G Potkin; John M Kane; Christoph U Correll; Jean-Pierre Lindenmayer; Ofer Agid; Stephen R Marder; Mark Olfson; Oliver D Howes
Journal:  NPJ Schizophr       Date:  2020-01-07

9.  Comparison of taurine, GABA, Glu, and Asp as scavengers of malondialdehyde in vitro and in vivo.

Authors:  Yan Deng; Wei Wang; Pingfeng Yu; Zhijiang Xi; Lijian Xu; Xiaolong Li; Nongyue He
Journal:  Nanoscale Res Lett       Date:  2013-04-24       Impact factor: 4.703

Review 10.  Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.

Authors:  G Morris; A J Walker; M Berk; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2017-10-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.